Genpact LTD
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(c) Director and Officer Trading Arrangements
The following table describes, for the quarterly period covered by this report, each trading arrangement for the sale or purchase of our securities adopted orterminated by our directors and officers that is either (1) a contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”) or (2) a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K):
| Name (Title) | Action Taken (Date of Action) | Type of Trading Arrangement | Nature of Trading Arrangement | Duration of Trading Arrangement | Aggregate Number of Securities |
|---|---|---|---|---|---|
| Heather White (Senior Vice President and Chief Legal Officer) | Adoption (August 12, 2025) | Rule 10b5-1 trading arrangement | Sale | Until February 9, 2026, or such earlier date upon which all transactions are completed | Up to 18,285 common shares(1) |
| Riju Vashisht (Senior Vice President, Chief Growth Officer and Global Business Leader, Enterprise Services and Partnerships & Alliances) | Adoption (September 11, 2025) | Rule 10b5-1 trading arrangement | Sale | Until February 2, 2026, or such earlier date upon which all transactions are completed | Up to 26,749 common shares(1) |
| Sameer Dewan (Senior Vice President, Global Business Leader, Financial Services) | Adoption (September 15, 2025) | Rule 10b5-1 trading arrangement | Sale | Until February 27, 2026, or such earlier date upon which all transactions are completed | Up to 24,868 common shares(1) |
| Anil Nanduru (Senior Vice President, Global Business Leader, High Tech & Manufacturing and Consumer & Healthcare) | Adoption (September 15, 2025) | Rule 10b5-1 trading arrangement | Sale | Until March 30, 2026, or such earlier date upon which all transactions are completed | Up to 26,773 common shares(1) |
(1) Includes shares underlying restricted share unit awards that have not yet vested. The actual number of shares to be sold under this arrangement will be net of the number of shares withheld to satisfy tax withholding obligations upon the vesting of such awards and is not yet determinable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.